Researcher

Wei Zhang is a Staff Scientist and Group Leader of the Downstream Processing Group (DSP) at A*STAR’s Bioprocessing Technology Institute (BTI). Her team focuses on the downstream process development and product analytics of a variety of novel biotherapeutics, ranging from monoclonal antibodies, bispecific antibodies, viral vectors, and vaccines. Her team is also committed to working towards intensified and continuous downstream processing. Her team in BTI actively collaborates with biopharmaceutical companies and bioprocessing solution providers worldwide, including leading industrial players and local SMEs. Prior to BTI, Wei Zhang worked as a Staff Scientist and Project Lead at Codexis Laboratories Singapore, where she led a multidisciplinary research team to generate new industrial biocatalysts using directed protein evolution tools and develop bio-catalysis processes to produce high-value APIs.